<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="106036">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02101762</url>
  </required_header>
  <id_info>
    <org_study_id>MII-001</org_study_id>
    <nct_id>NCT02101762</nct_id>
  </id_info>
  <brief_title>Study to Compare CAUTI Rates Following ERASE CAUTI Tray Non-Silver vs Silver Coated Foley Catheters</brief_title>
  <official_title>A Clinical Study to Compare the CAUTI Rates Following ERASE CAUTI Tray Non-Silver Coated Foley Catheters Verse Silver Coated Foley Catheters</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medline Industries</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medline Industries</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Foley catheter is one component in a catheter insertion procedure that  could contribute
      to a catheter associated urinary tract infection (CAUTI). Improvement in the catheter
      insertion procedures using the ERASE CAUTI Tray system may help to lower these infection
      rates.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>May 2014</start_date>
  <completion_date type="Anticipated">December 2015</completion_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Change in Urinary tract infection rates</measure>
    <time_frame>3-9 months based on size of ICU and catheter usage</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Infection rate/1000 catheter days.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Catheter use</measure>
    <time_frame>Catheter days</time_frame>
    <safety_issue>No</safety_issue>
    <description>Number of days catheters used.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Infection Costs</measure>
    <time_frame>Duration of infection</time_frame>
    <safety_issue>No</safety_issue>
    <description>Catheter related charges for infections</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">1500</enrollment>
  <condition>Surgery</condition>
  <condition>Intensive Care Units</condition>
  <arm_group>
    <arm_group_label>Silver Coated Catheters</arm_group_label>
    <description>Subjects that had previously received silver coated Foley catheters.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ERASE CAUTI Non-Silver Coated Catheters</arm_group_label>
    <description>Subjects that received non-silver catheters from an ERASE CAUTI tray.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects requiring urinary Foley catheters.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  At least 18 years of age

          -  Received Either silver coated Foley catheter or ERASE CAUTI non-silver coated
             catheter

        Exclusion Criteria:

          -  UTI present upon current hospital admission

          -  Burn patients, transplant patients, or immune-compromised patients.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Ed Drower, MS</last_name>
    <phone>847-643-3874</phone>
    <email>edrower@medline.com</email>
  </overall_contact>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 27, 2014</lastchanged_date>
  <firstreceived_date>February 9, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Foley</keyword>
  <keyword>Catheters</keyword>
  <keyword>CAUTI</keyword>
  <keyword>ERASE CAUTI</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
